TSHA
Taysha Gene Therapies, Inc.
NASDAQHealthcareBiotechnologyUS
USD7.02
+0.29 (+4.29%)
Rating:C
Company Profile
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$6.79
Prev. Close
$6.73
Day Low
$6.74
Day High
$7.04
52W Low
$2.25
52W High
$7.30
Market Cap
$1.76B
Volume
1.39M